7/27/2015 In a move opposed by many food and drink manufacturers, the Food and Drug Administration (FDA) issued a proposal on Friday to requiring the industry to include detailed added sugar consumption levels in their products. The proposal is an update to the FDA’s 2014 proposed mandate requiring companies to list the amount of added
7/24/2015 The U.S. Probation Office has recommended that the former owner of Peanut Corporation of America, Stewart Parnell, be sentenced to life in prison for allowing several shipments of peanuts from facilities infected with salmonella. The peanuts led to the deadliest food outbreak in U.S. history from 2008-2009, causing nine deaths and over 700 illnesses
7/23/2015 Los Angeles Food and Drug Administration (FDA) compliance officer Dr. Raymond W. Brullo issued a scathing warning letter to Thomas Ring, the CEO of New Jersey-based device manufacturer C.R. Bard. The letter contained a litany of violations regarding several single-use devices for IVC and foreign body retrieval. The letter follows a series of inspections
7/21/2015 A facility manager for Augusta, Georgia’s Charlie Norwood VA Medical Center has been indicted on 50 counts of instructing his staff to falsify medical records for patients seeking treatment outside of the VA health system. Cathedral Henderson pleaded not-guilty to the charges in U.S District Court in Savannah on Friday. Henderson managed revenue and
7/18/2015 The Food and Drug Administration (FDA) has given the recall of Medtronic’s Shiley neonatal and pediatric tracheostomy tubes a Class I label, its most serious designation. Under a Class I label, the FDA believes that “there is a reasonable probability that use of these products will cause serious adverse health consequences or death.” Last
7/15/2015 Biotech manufacturer Celgene is making an earnest push to become one of the industry’s leaders following a wave of transactions aimed at increasing long-term sustainability. Celgene’s current success is largely based on the popularity of its breakthrough cancer drug, Revlimid; however Celgene is attempting to set itself up for future growth when Revlimid’s patent
The U.S. Food and Drug Administration (FDA) is joining famous environmental and consumer activist Erin Brockovich in its skepticism of Bayer’s popular birth control device, Essure. Bayer claims that the coil-like device is the only non-surgical permanent form of birth control on the market. The FDA announced last month that it will be conducting a
7/8/2015 The U.S. Food and Drug Administration (FDA) released the results of a 1093-patient study on Tuesday of drugmaker, Eli Lilly’s experimental drug necitumumab, aimed at treating a certain form of lung cancer. The information comes as the FDA will be conducting a panel of outside experts on Thursday, July 9th that will review the
7/3/2015 Following last week’s landmark Supreme Court ruling on the Affordable Care Act (ACA), or Obamacare, two leading health insurers will be combining to form the second largest company in the industry. Aetna, the third-largest insurer will acquire Humana, the country’s fourth largest health plan provider. Aetna will pay a cash and stock equivalent to
7/2/2015 In what may be the largest whistleblower lawsuit ever, the Justice Department, along with 11 states, are accusing Swiss pharmaceutical titan, Novartis, of running a massive kickback scheme through the U.S. Medicare and Medicaid programs. Specifically, the U.S. is accusing the drugmaker of referring patients to a handful of specialty pharmacies who sent in